Graphene oxide reinforced chitosan/polyvinyl alcohol antibacterial coatings on stainless steel surfaces exhibit superior bioactivity without human cell cytotoxicity

The study proposes an alternative therapeutics to diminish bacterial attachment in biomedical implants by modifying their surface with passive coatings. A uniform, thin-film of chitosan/polyvinyl alcohol/graphene oxide (CS/PVA/GO) was coated on 316 L stainless steel (SS) surface through spread casting followed by solvent evaporation. The abundant anchoring sites available at macromolecular interfaces of chitosan/PVA matrix facilitated a smooth, dense loading of GO. The effect of GO content on physicochemical features, antibacterial potential, and biocompatibility of coatings was thoroughly studied. The hybrid films displayed good adhesion behavior, and UV-protection ability with desired mechanical and thermal stability when coated on SS surface. Coatings manifested a 1.5-1.7 fold rise in antibacterial efficacy against Staphylococcus epidermidis and Staphylococcus aureus and exhibited a permanent biocidal response after 6 h of contact-active behaviour. We investigated a 3-fold generation of reactive oxygen species as the predominant antibacterial mechanism, which diminishes bacterial integrity by inducing protein leakage (8.5-9 fold higher) and suppressing respiratory chain activity as two secondary mechanisms. All coatings with varying GO content appeared non-haemolytic (<2%) with ultra-low cytotoxicity (<29.08%) against human hepatocellular carcinoma (HepG2) and peripheral blood mononuclear cells. The degradation rate of coatings in simulated body fluid exhibited a higher stability, indicated by a lower weight loss (69-78%) and a decrease in pH values as the GO content in coatings increased from 0.05 to 0.15 wt%. Such anti-infective coating is a step forward in inhibiting bacterial colonization on SS surfaces to extend its lifespan.